These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8023842)
1. Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Chenevix-Trench G; Kerr J; Friedlander M; Hurst T; Sanderson B; Coglan M; Ward B; Leary J; Khoo SK Am J Hum Genet; 1994 Jul; 55(1):143-9. PubMed ID: 8023842 [TBL] [Abstract][Full Text] [Related]
2. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516 [TBL] [Abstract][Full Text] [Related]
3. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154 [TBL] [Abstract][Full Text] [Related]
4. Parkin gene alterations in ovarian carcinoma from northern Indian population. Mehdi SJ; Ali A; Rizvi MM Pathol Oncol Res; 2011 Sep; 17(3):579-86. PubMed ID: 21221875 [TBL] [Abstract][Full Text] [Related]
5. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cheng JQ; Jhanwar SC; Lu YY; Testa JR Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655 [TBL] [Abstract][Full Text] [Related]
6. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions. Walker GJ; Palmer JM; Walters MK; Nancarrow DJ; Parsons PG; Hayward NK Oncogene; 1994 Mar; 9(3):819-24. PubMed ID: 8108124 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas. Sakata K; Tamura G; Maesawa C; Suzuki Y; Terashima M; Satoh K; Eda Y; Suzuki A; Sekiyama S; Satodate R Jpn J Cancer Res; 1995 Apr; 86(4):333-5. PubMed ID: 7775254 [TBL] [Abstract][Full Text] [Related]
8. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351 [TBL] [Abstract][Full Text] [Related]
10. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239 [TBL] [Abstract][Full Text] [Related]
12. Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Shih YC; Kerr J; Liu J; Hurst T; Khoo SK; Ward B; Wainwright B; Chenevix-Trench G Int J Cancer; 1997 Mar; 70(5):508-11. PubMed ID: 9052747 [TBL] [Abstract][Full Text] [Related]
13. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750 [TBL] [Abstract][Full Text] [Related]
14. High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci. Devlin J; Elder PA; Gabra H; Steel CM; Knowles MA Br J Cancer; 1996 Feb; 73(4):420-3. PubMed ID: 8595153 [TBL] [Abstract][Full Text] [Related]
15. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522 [TBL] [Abstract][Full Text] [Related]
16. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080 [TBL] [Abstract][Full Text] [Related]
17. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers. Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138 [TBL] [Abstract][Full Text] [Related]
18. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Wang SI; Parsons R; Ittmann M Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796 [TBL] [Abstract][Full Text] [Related]
20. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]